Machine Learning-Driven Optimization of Therapeutic Substance Composition for High-Hardness, Fast-Dissolving Microneedles for Androgenetic Alopecia Treatment.

Journal: ACS nano
Published Date:

Abstract

Treating androgenetic alopecia (AGA) with platelet-rich plasma (PRP) holds great promise; however, effective and comfortable delivery remains a challenge. Direct injection causes pain, and PRP-incorporated microneedles (MNs) have low hardness and slow dissolution. To tackle this problem, we propose a machine-learning (ML)-driven strategy, which involves integrating the selection of therapeutic substances, orthogonal experiment designs, ML prediction, and Pareto front identification. Through the implementation of only 18 experiments based on orthogonal experiment designs, this ML-assisted strategy can pinpoint an optimal material composition that concurrently attains high hardness and rapid dissolution. We utilized this optimal material composition to fabricate MNs, and their biological functionality was demonstrated through multiple aspects, including the sustained release of various growth factors over 30 days, more than 90% bacterial inhibition, reactive oxygen species scavenging, and the promotion of the proliferation of dihydrotestosterone-damaged human dermal papilla cells. studies indicated significant hair regrowth in AGA mice through the activation of the Wnt/β-catenin pathway, outperforming the effects of minoxidil. Significantly, this approach eliminates the biosafety risks associated with the use of synthetic materials. The developed framework is anticipated to serve as a generalizable paradigm for expediting the clinical translation of biomaterials such as MNs.

Authors

  • Peiyu Yan
    Department of Dermatology, China-Japan Union Hospital of Jilin University, Changchun 130033, People's Republic of China.
  • Jing Sun
    Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yuehua Zhao
    State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, People's Republic of China.
  • Wei Deng
    Department of Neurobiology, Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. dengw@zju.edu.cn.
  • Miaomiao Zhang
    Department of Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Yang Li
    Occupation of Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xiangru Chen
    Beijing XiaoBaiShiJi Network Technical Co., Ltd, Beijing, 100084, China.
  • Ming Hu
    Department of Civil and Environmental Engineering and Earth Sciences, College of Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
  • Jilin Tang
    State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, People's Republic of China.
  • Dapeng Wang
    First Affiliated Hospital of Dalian Medical University, Dalian 116620, China.

Keywords

No keywords available for this article.